CHURCHILL CAPITAL CORP X C/WTS 14/05/2030(TO PUR COM)

Akanda

Agape ATP

Co-Diagnostics

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NewGenIvf

Tradr 2X Long QBTS Daily ETF

Tradr 2X Long RGTI Daily ETF

Defiance Daily Target 2X Long RGTI ETF

Liminatus Pharma

LAFAYETTE ACQUISITION CORP ORD USD0.0001(S/R)24/10/2030

CCCX

CCXIU

CCCXW

Churchill Capital XII, a SPAC founded by Michael Klein, has raised $360 million through an IPO by offering 36 million units at $10 each. Each unit includes one share of common stock and a warrant. The SPAC aims to target businesses with recurring revenue and strong management teams. Klein's previous SPACs include Churchill Capital XI and X, with various outcomes. The company will trade on Nasdaq under the symbol CXIIU, with Citi as the sole bookrunner.

RenaissanceCapital

Churchill Capital X

Churchill Capital XI - Unit

Citigroup

Infleqtion

Churchill Capital Corp IX

Lucid

Claritev

Churchill Capital Corp X - Unit

Infleqtion, Inc.

CITIGROUP INC 6.250 NON CUM SER II PFD WI

INFLEQTION INC C/WTS 17/02/2031 (TO PUR COM)

CLARITEV CORPORATION C/WTS 08/10/2025(TO PUR COM)

Michael Klein's SPAC Churchill Capital XII prices upsized $360 million IPO

CCCXU

Churchill Capital Corp XII Announces the Pricing of Upsized $360 Million Initial Public Offering | CXII Stock News

StockTitan

Churchill Capital Corp XII Announces the Pricing of Upsized $360 Million Initial Public Offering  | CXII Stock News

SPCK

Churchill Capital XII, a SPAC founded by Michael Klein, has filed for a $300 million IPO with the SEC. The company aims to offer 30 million units at $10 each, with each unit comprising one share of common stock and one-tenth of a warrant. The SPAC will target businesses with recurring revenue and stable cash flow. Klein's previous SPACs include successful mergers and some liquidations. The company plans to list on Nasdaq under the symbol CXIIU, with Citi as the sole bookrunner.

SPAC and New Issue ETF

Michael Klein's SPAC Churchill Capital XII files for a $300 million IPO

Churchill Wins TSXV Nod for Golden Baie Antimony-Gold Option in Newfoundland

Tip Ranks

Churchill Wins TSXV Nod for Golden Baie Antimony-Gold Option in Newfoundland

INFQ.WS

Earnings Watch

CHURCHILL CAPITAL CORP X C/WTS 14/05/2030(TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0

CHURCHILL CAPITAL CORP X C/WTS 14/05/2030(TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD 0.09

CHURCHILL CAPITAL CORP X C/WTS 14/05/2030(TO PUR COM)(CCCXW.US)

Michael Klein's SPAC Churchill Capital XII prices upsized $360 million IPO

Churchill Capital Corp XII Announces the Pricing of Upsized $360 Million Initial Public Offering | CXII Stock News

Michael Klein's SPAC Churchill Capital XII files for a $300 million IPO

Churchill Wins TSXV Nod for Golden Baie Antimony-Gold Option in Newfoundland

CHURCHILL CAPITAL CORP X C/WTS 14/05/2030(TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0

CHURCHILL CAPITAL CORP X C/WTS 14/05/2030(TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD 0.09